Advanced search
Publication Cover
Leukemia & Lymphoma Volume 5, 1991 - Issue sup1
Submit an article Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Combined use of Alpha 2b Interferon and Chlorambucil in the Management of Previously Treated B-Cell Chronic Lymphocytic Leukemia

Massimo Pini Dipartimento di Scienze Biomediche ed Oncologia Umana, Sezione Clinica and Centro CNR “Immunogenetica ed Istocompatibilita”, University of Torino, Italy
&
Robin Foa Dipartimento di Scienze Biomediche ed Oncologia Umana, Sezione Clinica and Centro CNR “Immunogenetica ed Istocompatibilita”, University of Torino, Italy
Pages 143-148 | Published online: 01 Jul 2009

References

  • Quesada J. R., Reuben J., Manning J. T., Hersch E. M., Gutterman J. U. Alpha interferon for the induction of remission in hairy-cell leukemia. New England Journal of Medicine 1984; 310: 15–18
  • Ratain M. H., Golomb H. M., Vardiman J. W., Vokes E. E., Jacobs R. M., Daly K. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood 1985; 65: 644–48
  • Lauria F., Foa R., Raspadori D. Treatment of hairy-cell leukaemia with α-Interferon (α-IFN). European Journal Cancer and Clinical Oncology 1988; 24: 195–200
  • Talpaz M., Kantarjian H. M., McCredie K., Trujillo J. M., Keating M. J., Gutterman J. U. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. New England Journal of Medicine 1986; 314: 1065–69
  • Alimena G., Morra E., Lazzarino M. Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration. Blood 1988; 72: 642–47
  • Merigan T. C., Sikora K., Breeden J. H., Levy R., Rosenberg S. A. Preliminary observations on the effect of human leukocyte interferon in non-Hodgbkin's lymphoma. New England Journal of Medicine 1978; 299: 1449–53
  • Foon K. A., Sherwin S. A., Abrams P. G. Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte alpha interferon. New England Journal of Medicine 1984; 311: 1449–53
  • Horning S. J., Merigan T. C., Krown S. E. Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society Trial. Cancer 1985; 56: 1305–10
  • Bunn P. A., Foon K. A., Ihde D. C. Recombinant leukocyte a interferon: an active agent in advanced cutaneous T-cell lymphomas. Annals of Internal Medicine 1984; 101: 484–87
  • Ohno R., Kimura K. Treatment of multiple myeloma with recombinant interferon-alfa-2a. Cancer 1986; 57: 1685–88
  • Mandelli F., Avvisati G., Amadori S. Maintenance treatment with recombinant interferon alpha-2b in patients with multiple myeloma responding to conventional induction chemotherapy. New England Journal of Medicine 1990; 322: 1430–34
  • Giles F. J., Gray A. G., Brozovic M. Alpha-interferon therapy for essential thrombocythaemia. Lancet 1988; 2: 70–72
  • Foon K. A., Bottino G. C., Abrams P. G. Phase II trial of recombinant leukocyte interferon in patients with advanced chronic lymphocytic leukemia. American Journal of Medicine 1985; 78: 216–20
  • O'Connell M. J., Colgan J. P., Oken M. M. Clinical trial of recombinant leukocyte α interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia an Eastern Cooperative Oncology Group pilot study. Journal of Clinical Oncology 1986; 4: 128–36
  • Roth M. S., Foon K. A. Alpha interferon in the treatment of hematologic malignancies. American Journal of Medicine 1986; 67: 152–59
  • Pangalis G. A., Griva E. Recombinant alfa-2b-interferon therapy in untreated, stages A and B chronic lymphocytic leukemia. Cancer 1988; 61: 869–72
  • Rozman C., Montserrat E., Vinolas N. Recombinant alpha 2 interferon in the treatment of B, chronic lymphocytic leukemia in early stages. Blood 1988; 71: 1295–98
  • Ziegler-Heitbrock H. W. L., Schlag R., Flieger D., Thioel E. Favorable response of early stage B CLL patients to treatment with IFN alpha2. Blood 1989; 73: 1426–30
  • Bonnem E. M. Alpha interferon: combinations with other antineoplastic modalities. Seminars in Oncology 1987; 14: 48–60
  • Balkwill F. R., Moodie E. M. Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system. Cancer Research 1984; 44: 904–09
  • Durie B. G. M., Clouse L., Braich T., Grimm M., Robertone A. B. Interferon alfa-2b-cyclophosphamide combination studies: in vitro and phase I–II clinical results. Seminars in Oncology 1986; 13: 84–88
  • Chisesi T., Capnist G., Vespignani M., Cetto G. Interferon alpha-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Investigational New Drugs 1987; 5: 35–50
  • Rohatiner A. Z. S., Richards M. A., Barnett M. J., Stansfeld A. G., Lister T. A. Chlorambucil and interferon αfor low grade non Hodgkin's lymphoma. British Journal of Cancer 1987; 55: 225–26

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.